We collaborate with investigators to solve research challenges.
Whether you are planning a new study, optimizing an existing project, or facing challenges with limited sample volume, tight timelines, or budget constraints, BAL is ready to partner with you.
The CCTS Biomarker Analysis Lab (BAL) provides comprehensive biomarker analysis services to support both basic science and clinical research. We combine advanced immunoassay technologies with expert experimental design to help investigators generate high-quality data while saving time, reducing costs, and preserving valuable samples. Our goal is to deliver reliable, high-quality biomarker analysis and practical scientific solutions—along with potential financial assistance for our services—that move your research forward.
BAL offers ultrasensitive ELISA and multiplex immunoassays capable of detecting biomarkers at fg/mL levels. Whether your study requires measurement of a single analyte or dozens of biomarkers, BAL can recommend the most efficient approach. Using multiplex technology, we can quantify up to 10 biomarkers from as little as 25 µL of sample, making it possible to obtain comprehensive data from limited specimens.
To further support investigators, BAL partners with the CCTS Pilot Funding Program to provide financial assistance to investigators with limited research funding.
By combining technical expertise, innovative assay design, collaborative consultation, and funding support, BAL helps researchers overcome technical and financial barriers to accelerate scientific discovery.
BAL also:
- maintains a YSI glucose analyzer for point of care glucose measurements
- provides sample processing/storage for human fluids, muscle biopsy IHC mounts, etc.
- provides cost estimates for grant submission.
Newly Available Ultrasensitive S-Plex Assays from Meso Scale (fg/mL):
